Angela Braly - Procter Gamble Independent Director

PG -  USA Stock  

USD 148.90  5.78  3.74%

  Director
Ms. Angela F. Braly is an Independent Director of the Company. Ms. Braly is the former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc., now known as Anthem, Inc. She served as Chair of the Board from 2010 to 2012 and as President and Chief Executive Officer from 2007 to 2012. She previously served as Executive Vice President, General Counsel, and Chief Public Affairs Officer of WellPoint from 2005 to 2007, and President and Chief Executive Officer of Blue Cross Blue Shield of Missouri from 2003 to 2005. Ms. Braly was a Director of Lowes Companies, Inc. since 2013, Brookfield Asset Management since 2015, and ExxonMobil Corporationrationration since 2016. Ms. Bralys diverse Leadership, Strategy, and Risk Management experience at WellPoint enables her to provide valuable insight about risk management and governance matters, particularly as it pertains to the Consumer IndustryRetail sector, to the Board. Additionally, her role as General Counsel and Chief Public Affairs Officer for WellPoint, where she was responsible for the companys government relations, public policy development, social responsibility, and corporate governance initiatives, and her experience on other public company boards enables her to bring significant Corporationrationrate Governance expertise and GovernmentRegulatory skills to the Board, which is critical during current times of political and economic uncertainty.
Age: 59  Director Since 2009      
513 983 1100  https://www.pginvestor.com

Angela Braly Latest Insider Activity

Tracking and analyzing the buying and selling activities of Angela Braly against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Angela Braly insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Procter Gamble Management Efficiency

Procter Gamble has Return on Asset (ROA) of 9.51 % which means that for every $100 of asset, it generated profit of $9.51. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 31.09 %, which means that it produced $31.09 on every 100 dollars invested by current stockholders. Procter Gamble management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company reports 35.65 B of total liabilities with total debt to equity ratio (D/E) of 0.79, which is normal for its line of buisiness. Procter Gamble has a current ratio of 0.66, implying that it has not enough working capital to pay out debt commitments in time. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine Procter Gamble value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Similar Executives

Showing few of many executives

DIRECTOR Since

Phyllis WiseNike Inc
2014
Dessislava TemperleyPhilip Morris International
2021
Nancy MistrettaScotts Miracle-Gro
2007
John ConnorsNike Inc
2005
Robert WrightRalph Lauren Corp
2007
Werner GeisslerPhilip Morris International
2015
Michael TodmanNewell Brands
2007
Harold BrownPhilip Morris International
2008
Laura NathansonNu Skin Enterprises
2019
Andrew LanghamNewell Brands
2018
Alan GrafNike Inc
2014
Arnold AronsonRalph Lauren Corp
2018
Stephen JohnsonScotts Miracle-Gro
2010
John VinesScotts Miracle-Gro
2014
Zhequing ShenNu Skin Enterprises
2016
Martin FranklinNewell Brands
2016
Xinzhe LiPhilip Morris International
2010
Domenico SoleNewell Brands
2007
Steven StrobelNewell Brands
2006
Johnathan RodgersNike Inc
2006
John RogersNike Inc
2018
The Procter Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. Procter Gamble operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 101000 people. Procter Gamble (PG) is traded on New York Stock Exchange in USA and employs 101,000 people.

Procter Gamble Leadership Team

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, Chief Research, Development and Innovation Officer
Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures
Kenneth Chenault, Independent Director
Debra Lee, Independent Director
Mindy Sherwood, President Global Walmart
Amy Chang, Independent Director
Nelson Peltz, Independent Director
Martin Riant, Group Pres and Advisor to the CEO
Hatsunori Kiriyama, President - Asia
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations
Kirti Singh, Chief Analytics and Insights Officer
Tarek Farahat, President - Latin America
Francis Blake, Independent Director
Thomas Finn, President - Personal Health Care
Mohamed Samir, President - India, Middle East and Africa (IMEA) Selling and Market Operations
Alexandra Keith, President - Global Hair Care and Beauty Sector
Susan DesmondHellmann, Independent Director
Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader
Fama Francisco, Chief Executive Officer - Baby and Feminine Care
Loic Tassel, President - Europe
Margaret Whitman, Independent Director
Walter McNerney, Lead Independent Director
Terry Lundgren, Independent Director
Shelly McNamara, Senior Vice President of Human Resources
Angela Braly, Independent Director
Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care
M Grabowski, Chief Human Resource Officer
Victor Aguilar, Chief Research, Development and Innovation Officer
Javier Polit, Chief Information Officer
B Allen, Independent Director
James McNerney, Lead Independent Director
Ernesto Zedillo, Independent Director
Steven Bishop, Group President - Global Feminine and Family Care
Scott Cook, Independent Director
Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China
Sundar Raman, President - Fabric Care, North America and P&G Professional, Global
Ernesto Leon, Independent Director
R Keith, President - Global Hair Care and Beauty Sector
Ma Francisco, Chief Executive Officer - Baby and Feminine Care
Yannis Skoufalos, Global Product Supply Officer
Linda ClementHolmes, CIO
Jennifer Davis, President - Feminine Care
John Chevalier, Director - Investor Relations
Juan Posada, President - Latin America Selling and Market Operations
Alan Lafley, Executive Chairman and Member of Proxy Committee
Jeffrey Schomburger, Global Sales Officer
Monica Turner, Senior Vice President - Sales, North America
Vittorio Cretella, Chief Information Officer
Christine McCarthy, Independent Director
Patricia Woertz, Independent Director
Shailesh Jejurikar, Chief Operating Officer, Chief Executive Officer - Fabric and Home Care
Philip Duncan, Chief Design Officer
Andre Schulten, Chief Financial Officer
Marc Pritchard, Global Brand Building Officer
Markus Strobel, President - Skin & Personal Care
David Taylor, Chairman of the Board, President, Chief Executive Officer
Mark Biegger, Global Human Resources Officer
Joseph Jimenez, Lead Independent Director
Matthew Price, President - Greater China Selling and Market Operations
Julio Nemeth, President - Global Business Services
Laura Becker, President - Global Business Services
Deborah Majoras, Chief Legal Officer, Secretary
Jon Moeller, Vice Chairman of the Board, President, Chief Executive Officer
Patrice Louvet, Group President - Global Beauty
Charles Pierce, Group President - Global Grooming
Gary Coombe, President - Europe Selling and Market Operations
Carolyn Tastad, Group President - North America Selling and Market Operations

Procter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Procter Gamble Investors Sentiment

The influence of Procter Gamble's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Procter. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Procter Gamble Implied Volatility

    
  31.11  
Procter Gamble's implied volatility exposes the market's sentiment of Procter Gamble stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Procter Gamble's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Procter Gamble stock will not fluctuate a lot when Procter Gamble's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Procter Gamble in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Procter Gamble's short interest history, or implied volatility extrapolated from Procter Gamble options trading.

Current Sentiment - PG

Procter Gamble Investor Sentiment

Nearly all of Macroaxis users are at this time bullish on Procter Gamble. What is your perspective on investing in Procter Gamble? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Procter Stock analysis

When running Procter Gamble price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine Procter Gamble value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.